![Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology](https://www.thelancet.com/cms/attachment/04828f61-596a-4e20-8bd5-ddb7d270a44a/gr1_lrg.jpg)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology
![PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2a5cff93f34ad2baa7b2ce48db639064f71d844d/5-Table3-1.png)
PDF] Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. | Semantic Scholar
![Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration | Scientific Reports Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-48465-x/MediaObjects/41598_2019_48465_Fig1_HTML.png)
Prediction of Treatment Response to Neoadjuvant Chemotherapy for Breast Cancer via Early Changes in Tumor Heterogeneity Captured by DCE-MRI Registration | Scientific Reports
![Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017) Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017)](https://jnccn.org/view/journals/jnccn/15/10/1216fig04.jpeg)
Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer in: Journal of the National Comprehensive Cancer Network Volume 15 Issue 10 (2017)
![Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium - European Urology Focus Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/4fc9002f-6658-44c7-bc7f-899d852f18d9/gr1.jpg)
Nomogram Predicting Bladder Cancer–specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium - European Urology Focus
![Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients | BMC Urology | Full Text Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-020-00733-z/MediaObjects/12894_2020_733_Fig1_HTML.png)
Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients | BMC Urology | Full Text
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/34b2410d-db54-46e1-ac1d-1d1894292938/gr1_lrg.gif)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence | Radiology Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2018172888/asset/images/medium/radiol.2018172888.fig1.gif)
Neoadjuvant Chemotherapy and Surgery for Breast Cancer: Preoperative MRI Features Associated with Local Recurrence | Radiology
![Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ](https://www.hkmj.org/system/files/hkmj164972-table4.jpg)
Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer | HKMJ
![Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 - Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -](https://onlinelibrary.wiley.com/cms/asset/0af844b9-eb20-4faf-94fe-5ce12e04c05a/ijc34022-toc-0001-m.png)
Survival outcomes for dose‐dense paclitaxel plus carboplatin neoadjuvant vs standard adjuvant chemotherapy in stage II to III triple‐negative breast cancer: A prospective cohort study with propensity‐matched analysis - Xiu - 2022 -
![Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - ScienceDirect Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022522318326060-gr1.jpg)
Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis - ScienceDirect
![Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on](https://cyberleninka.org/viewer_images/1267801/f/1.png)
Meta-analysis on the association between pathologic complete response and triple-negative breast cancer after neoadjuvant chemotherapy – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on
Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database | PLOS ONE
![Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-017-1273-6/MediaObjects/12957_2017_1273_Fig1_HTML.gif)
Oncological outcome of complete response after neoadjuvant chemotherapy for breast conserving surgery: a systematic review and meta-analysis | World Journal of Surgical Oncology | Full Text
![Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | SpringerLink Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-019-07534-1/MediaObjects/10434_2019_7534_Fig1_HTML.png)
Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option? | SpringerLink
![Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-19933-0/MediaObjects/41467_2020_19933_Fig1_HTML.png)
Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome | Nature Communications
![PDF) Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials PDF) Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials](https://i1.rgstatic.net/publication/279304131_Outcome_after_neoadjuvant_chemotherapy_in_young_breast_cancer_patients_a_pooled_analysis_of_individual_patient_data_from_eight_prospectively_randomized_controlled_trials/links/56af21e308ae28588c62d2a7/largepreview.png)